Key Record Dates Identifier: NCT01848652
Brief Title: Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine. (MYLY)

First Submitted : May 3, 2013
First Submitted that Met QC Criteria : May 3, 2013
First Posted : May 7, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 13, 2015
Last Update Posted : July 14, 2015 (Estimate)